Massmutual Trust »

Rapport Therapeutics shares owned by Massmutual Trust

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Massmutual Trust from 13F filings

Historical chart of Massmutual Trust investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Massmutual Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Massmutual Trust

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.9k 161 30.34

More positions owned by Massmutual Trust

NVIDIA Corp Common / Ordinary Stock (NVDA)
Apple Common / Ordinary Stock (AAPL)
Microsoft Corp Common / Ordinary Stock (MSFT)
Vanguard Mid-Cap ETF Exchange Traded Fund (VO)
Amazon.com Common / Ordinary Stock (AMZN)
Alphabet Common / Ordinary Stock (GOOGL)
Vanguard FTSE Developed Markets ETF Exchange Traded Fund (VEA)
JPMorgan Chase & Co Common / Ordinary Stock (JPM)
Broadcom Common / Ordinary Stock (AVGO)
Alphabet Common / Ordinary Stock (GOOG)
Meta Platforms Common / Ordinary Stock (META)
iShares MSCI EAFE ETF Exchange Traded Fund (EFA)
Dimensional US Small Cap ETF Exchange Traded Fund (DFAS)
Visa Common / Ordinary Stock (V)
iShares Core S&P Mid-Cap ETF Exchange Traded Fund (IJH)

View all positions for Massmutual Trust

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics